Determinants of smoking behaviour in outpatients with schizophrenia

被引:79
|
作者
Herrán, A [1 ]
de Santiago, A [1 ]
Sandoya, M [1 ]
Fernández, MJ [1 ]
Díez-Manrique, JF [1 ]
Vázquez-Barquero, JL [1 ]
机构
[1] Univ Hosp Marques Valdecilla, Dept Psychiat, Clin & Social Psychiat Res Unit, Santander 39008, Spain
关键词
anxiety; dependence; nicotine; personality traits; schizophrenia; smoking;
D O I
10.1016/S0920-9964(99)00082-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The present study is an assessment of the rate and severity of tobacco consumption in outpatients with schizophrenia, and the determinants of smoking behaviour. Sixty-four patients, assessed by the Item Group Checklist section of the SCAN interview and fitting DSM-IV criteria, were evaluated with CGI and the PANSS scales. In addition, they completed STAI (Spielberger), EPQ (Eysenck), and TPQ (Cloninger) questionnaires. Tobacco dependence was assessed by the Fagerstrom test. One hundred and thirty-seven consecutive outpatients were psychiatric controls. Forty-one out of 64 patients with schizophrenia (64.1%) were current smokers, this rate being significantly higher than in other psychiatric patients and general population. The severity of cigarette consumption in smokers was greater (mean of 22.4 cigarettes/day) than in the general population, but it was not different from that of other psychiatric patients. For patients with schizophrenia, no one variable (except male sex) was different between smokers and non-smokers, but the number of cigarettes/day correlated with state anxiety, trait anxiety, and neuroticism. In the multivariate analysis, the only variable that remained significant was neuroticism. The relationship between clinical features and severity of smoking behaviour may be linked to non-specific variables such as neuroticism and anxiety, but not to psychotic symptoms. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 50 条
  • [1] Neurobiological Determinants of Tobacco Smoking in Schizophrenia
    Lucatch, Aliya M.
    Lowe, Darby J. E.
    Clark, Rachel C.
    Kozak, Karolina
    George, Tony P.
    [J]. FRONTIERS IN PSYCHIATRY, 2018, 9
  • [2] Effects of abstinence on cigarette smoking among outpatients with schizophrenia
    Tidey, JW
    O'Neill, SC
    Higgins, ST
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1999, 7 (04) : 347 - 353
  • [3] Determinants of Quality of Life in Spanish outpatients with schizophrenia spectrum disorders
    Arraras, J. I.
    Ibanez, B.
    Basterra, I.
    Pereda, N.
    Martin, M.
    Iribarren, S.
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2018, 32 (03): : 113 - 121
  • [4] Determinants of Smoking Status in a Sample of Outpatients Afferent to a Tertiary Referral Hospital
    Radaeli, Alessandro
    Nardin, Matteo
    Azzolina, Danila
    Malerba, Mario
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (21)
  • [5] Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia
    Eskelinen, Saana
    Sailas, Eila
    Joutsenniemi, Kaisla
    Holi, Matti
    Suvisaari, Jaana
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2015, 69 (05) : 339 - 345
  • [6] SMOKING BY OUTPATIENTS
    BRECKENRIDGE, JS
    [J]. HOSPITAL AND COMMUNITY PSYCHIATRY, 1990, 41 (04): : 454 - 455
  • [7] Psychological determinants of adolescent smoking behaviour: A prospective study
    Byrne, DG
    Reinhart, MI
    [J]. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 1998, 50 (01) : 29 - 34
  • [8] Determinants of various aspects of smoking behaviour in the United States
    Goel, Rajeev K.
    Naretta, Michael A.
    [J]. APPLIED ECONOMICS LETTERS, 2011, 18 (17) : 1671 - 1675
  • [9] Determinants of smoking behaviour among adolescents in Semarang, Indonesia
    Smet, B
    Maes, L
    De Clercq, L
    Haryanti, K
    Winarno, RD
    [J]. TOBACCO CONTROL, 1999, 8 (02) : 186 - 191
  • [10] Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia
    Tidey, JW
    O'Neill, SC
    Higgins, ST
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2002, 10 (03) : 241 - 247